The Cellular and Molecular Mechanisms of Pemetrexed-mediated Antitumor Effects in Human Non-small-cell Lung Cancer Cells
博士 === 中山醫學大學 === 醫學研究所 === 101 === Objective:Pemetrexed, a multitargeted antifolate with the ability to inhibit several enzymes, including thymidylate synthase、glycinamide ribonucleotide formyltransferase、dihydrofolate reductase, which involved in purine and pyrimidine synthesis, has demonstrated c...
Main Authors: | Tsung-Ying Yang, 楊宗穎 |
---|---|
Other Authors: | 許國堂 |
Format: | Others |
Language: | zh-TW |
Published: |
2013
|
Online Access: | http://ndltd.ncl.edu.tw/handle/86038617558174670761 |
Similar Items
-
Investigation of Pemetrexed(Alimta)cytotoxicity with non-small cell lung cancer cell lines
by: Chia-Chia, et al.
Published: (2007) -
Safety and Efficacy of Pemetrexed in Maintenance Therapy of Non-Small Cell Lung Cancer
by: Michel Velez, et al.
Published: (2012-01-01) -
Safety and Efficacy of Pemetrexed in Maintenance Therapy of Non-Small Cell Lung Cancer
by: Michel Velez, et al.
Published: (2012-02-01) -
Pemetrexed for Heavily Pretreated Patients With Advanced Non-small Cell Lung Cancer
by: Jih-Hsiang Lee, et al.
Published: (2010-05-01) -
Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer
by: Serena Ricciardi, et al.
Published: (2009-09-01)